(Size: 50 µg)
Click on the image to see the image legend
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein (NP) Antibody is a chimaeric recombinant Monoclonal Antibody expressed in CHO cells against SARS-CoV-2/COVID-19 NP, containing Mouse variable region and Human IgG1 constant region.
The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.
Research Articles on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein
||Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein
||ELISA: 1/5000 - 1/10,000, WB: 1/1000 - 1/2000. Optimal dilutions/concentrations should be determined by the end user.
||Recombinant SARS-CoV-2 Nucleocapsid Protein
||Purified by affinity chromatography.
||Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
||PBS, pH 7.5.
||Shipped within 5-10 working days.
||This product is for research use only.